CNS Pharmaceuticals, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
1.46M
on 2026-06-30, from 356 on 2024-03-31 10-Q ↗
Earlier counts are adjusted for three reverse splits; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3 of 2024-05-09. Not read yet. S-3 ↗
25 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-12 is not read yet.
Cash
6 quarters
$20.0M on 2026-06-30 ÷ $3.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-05-04 | Private placement | 9,143,479 | $2.30 | $22.5M | 8-K ↗ |